Alvogen opened its office in Zagreb in October 2011. Market focus is on sales and marketing of biosimilar and generic hospital products. Croatian team currently has six dedicated people, led by Ivana Stojcevic, Country Manager.
Croatian pharmaceutical market reached a value of $1,2 billion and it is one of the biggest markets in the region, though with only 4.5 million inhabitants.
Through strategic alliances, smart portfolio development and a strong sales team, Alvogen goal is to keep a leader position in bringing high-tech products such as biosimilars and top quality hospital generics to Croatian market.